TrialPloS one2018

Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial.

Stefan Bilz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.